Amgen (AMGN) Gross Profit (2009 - 2026)

Amgen's Gross Profit history runs 18 years deep, the most recent figure standing at $5.9 billion for Q1 2026.

• In Q1 2026, Gross Profit rose 13.38% year-over-year to $5.9 billion; the TTM figure through Mar 2026 stood at $39.1 billion (up 57.91% YoY), while the FY2025 annual figure was $35.4 billion, up 72.32% from the prior year.
• Gross Profit was $5.9 billion for Q1 2026 at Amgen, down from $17.6 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $17.6 billion in Q4 2025 to a low of -$1.3 billion in Q4 2022.
• Historically, Gross Profit has averaged $6.1 billion across 5 years, with a median of $5.2 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Gross Profit sank 111.31% in 2022, then soared 494.72% in 2023.
• A 5-year view of Gross Profit shows it stood at -$1.3 billion in 2022, then jumped by 494.72% to $5.1 billion in 2023, then advanced by 17.51% to $6.0 billion in 2024, then jumped by 194.86% to $17.6 billion in 2025, then plunged by 66.65% to $5.9 billion in 2026.
• The last three Gross Profit figures came in at $5.9 billion (Q1 2026), $17.6 billion (Q4 2025), and $6.5 billion (Q3 2025), per Business Quant data.